A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus

Clinical trial NCT00630825 · COMPLETED

Trial details

NCT number: NCT00630825
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2008-04-01
Primary completion: 2009-01-01
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.